BMEA
Biomea Fusion, Inc.
There isn't enough reported data to score BMEA yet.
BMEA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
BMEA's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
BMEA PE Valuation
BMEA has no meaningful PE right now: it lost money over the past year.
BMEA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect BMEA's losses to shrink, with revenue growing.
BMEA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.30 | +$2.09 |
| Q2 2026 | -$0.48 | +$2.55 |
| Q1 2026 | -$0.87 | +$2.68 |
| Q4 2025 | -$1.50 | +$2.34 |
| Q3 2025 | -$2.39 | +$1.62 |
| Q2 2025 | -$3.03 | +$0.87 |
| Q1 2025 | -$3.55 | +$0.02 |
| Q4 2024 | -$3.84 | -$0.38 |
BMEA is still losing money, but far less than before: $0.30 per share over the past year, against $4.01 at its worst in late 2024.
BMEA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2022 | $1.1B | 0% |
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2022 | -14% | N/A |
| Q1 2022 | -1.5% | -1 points |
| Q1 2021 | -0.6% | N/A |
BMEA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.4M | +$3.1M |
| Q2 2026 | -$10M | +$9.2M |
| Q1 2026 | -$11.7M | +$14M |
| Q3 2025 | -$11.6M | +$13.9M |
| Q2 2025 | -$19.2M | +$13.5M |
| Q1 2025 | -$25.7M | +$6.4M |
| Q4 2024 | -$30.1M | -$7.2M |
| Q3 2024 | -$25.4M | -$1.5M |
BMEA has burned cash in almost every quarter: −$42M over the past year, against −$100M the year before.
BMEA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +232K shares |
| 1 year | +79% | +32M shares |
| 3 years | +105% | +37.2M shares |
| 5 years | +189% | +47.4M shares |
BMEA has 73M diluted shares, up 79% from a year ago.
BMEA Net Leverage
BMEA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BMEA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.0 | Neutral |
| Stochastic | 3.0 | Oversold |
BMEA's weekly RSI is 35 (neutral) and its Stochastic is 3 (oversold).
BMEA PE vs Healthcare Sector
BMEA has no meaningful PE right now: it lost money over the past year.
BMEA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.91 | 38% below |
| 20 week MA | $1.25 | 55% below |
| 50 week MA | $1.34 | 58% below |
| 100 week MA | $1.81 | 69% below |
| 200 week MA | $8.24 | 93% below |
BMEA is in a downtrend: it's below all five of its weekly moving averages, and 93% below its 200-week average.
BMEA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $18.6 | $7.81 | -58% |
| 2022 | $7.81 | $7.77 | -0.5% |
| 2023 | $7.77 | $14.5 | +87% |
| 2024 | $14.5 | $4.00 | -72% |
| 2025 | $4.00 | $1.32 | -67% |
| 2026 YTD | $1.32 | $0.56 | -58% |
BMEA has finished lower in four of the last five years. It's down 58% so far in 2026.